Healthcare / Medical DistributionFrankfurt
$60.00
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 23% · confianza 25%
FCF escenarios
weak_data · normalized FCF $12.6M · quality 77.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
49/100
C
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$493M
P/E
29.6x
↑EV/EBITDA
16.6x
↑ROE
18.4%
↑Gross Margin
12.0%
↓Debt/Equity
0.29
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+12.0%
FCF CAGR
+11.5%
FCF margin
1.8%
FCF / Net income
0.75x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $696.2M · net income $16.7M · FCF $12.6M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $696.2M | $696.2M | $648.8M | $599.4M | $495.7M |
| Net Income | $16.7M | $16.7M | $12.9M | $10.3M | $13.1M |
| EBITDA | $30.5M | $30.5M | $25.6M | $19.5M | $21.2M |
| EPS | 2.03 | 2.03 | 1.56 | 1.25 | 1.61 |
| Gross Margin | 12.0% | 12.0% | 11.3% | 10.0% | 10.9% |
| Operating Margin | 2.8% | 2.8% | 2.6% | 2.2% | 3.3% |
| Net Margin | 2.4% | 2.4% | 2.0% | 1.7% | 2.6% |
| Balance Sheet | |||||
| Debt/Equity | 0.29 | 0.29 | 0.22 | 0.29 | 0.22 |
| Current Ratio | 1.33 | 1.33 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $12.6M | $12.6M | $8.0M | $15.5M | $9.1M |
| Returns | |||||
| ROE | 18.4% | 18.4% | 15.5% | 13.2% | 17.7% |
| Valuation | |||||
| P/E | 29.56 | 29.56 | — | — | — |
| EV/EBITDA | 16.58 | 16.58 | — | — | — |
| P/B | 5.43 | 5.43 | — | — | — |
| Growth & Yield | |||||
| Revenue Growth | 7.3% | 7.3% | 8.2% | 20.9% | — |
| EPS Growth | 30.1% | 30.1% | 24.3% | -22.0% | — |
| Dividend Yield | 2.0% | 2.0% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
37.9%
EPS terminal req.
$5.32
Spread vs growth
-7.8%
5Y implied EPS CAGR
26.0%
EPS terminal req.
$6.44
Spread vs growth
4.1%
10Y implied EPS CAGR
17.7%
EPS terminal req.
$10.37
Spread vs growth
12.4%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+29.7%
Start / end P/E
30.1x → 29.6x
EPS bridge
1.56 → 2.03
Residual
-0.6%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.